{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:37:25Z","timestamp":1774125445227,"version":"3.50.1"},"reference-count":32,"publisher":"Massachusetts Medical Society","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2000,4,13]]},"DOI":"10.1056\/nejm200004133421503","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:55:44Z","timestamp":1027760144000},"page":"1085-1092","source":"Crossref","is-referenced-by-count":121,"title":["Discontinuation of Prophylaxis against<i>Mycobacterium avium<\/i>Complex Disease in HIV-Infected Patients Who Have a Response to Antiretroviral Therapy"],"prefix":"10.1056","volume":"342","author":[{"given":"Wafaa M.","family":"El-Sadr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Burman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Bjorling","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Matts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug","family":"Zeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon B.","family":"Mannheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"Gordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"150","reference":[{"key":"r001","doi-asserted-by":"crossref","first-page":"633","DOI":"10.7326\/0003-4819-124-7-199604010-00003","volume":"124","author":"Moore RD","year":"1996","journal-title":"Ann Intern Med"},{"key":"r002","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.14.1537"},{"key":"r003","doi-asserted-by":"publisher","DOI":"10.1086\/514566"},{"key":"r004","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350604"},{"key":"r005","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608083350603"},{"key":"r006","unstructured":"Benson CA, Cohn DL, Williams P, ACTG 196\/CPCRA 009 Study Team. A phase III prospective, randomized, double-blind study of the safety and efficacy of clarithromycin vs. rifabutin, vs. clarithromycin plus rifabutin for prevention of Mycobacterium avium complex disease in HIV+ patients with CD4 counts less than or equal to 100 cells\/uL. In: Program and abstracts of the Third Conference on Retroviruses and Opportunistic Infections, Washington, D.C., January 28\u2013February 1, 1996. Alexandria, Va.: IDSA Foundation for Retrovirology and Human Health, 1996:91. abstract."},{"key":"r007","first-page":"1","volume":"46","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"r008","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)10328-8"},{"key":"r009","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709113371101"},{"key":"r010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803263381301"},{"key":"r011","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.6.1082"},{"key":"r012","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.5.491"},{"key":"r013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199509283331305"},{"key":"r014","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)03287-0"},{"key":"r015","unstructured":"Dworkin M, Hanson D, Jones J, Kaplan J. The risk for Pneumocystis carinii pneumonia and disseminated nontuberculous mycobacteriosis after antiretroviral therapy associated increase in the CD4+ T-lymphocyte count. In: Program and abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, January 31\u2013February 4, 1999. Alexandria, Va.: Foundation for Human Retrovirology, 1999:198. abstract."},{"key":"r016","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07204-3"},{"key":"r017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199904293401701"},{"key":"r018","unstructured":"Lopez JC, Pena JM, Miro JM, Podsamczer D. Discontinuation of PCP prophylaxis is safe in HIV-infected patients with immunological recovery with HAART: preliminary results of an open, randomized and multicentric clinical trial (GESIDA A04\/98). In: Program and abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections, Chicago, January 31\u2013February 4, 1999. Alexandria, Va.: Foundation for Human Retrovirology, 1999:206. abstract."},{"key":"r019","first-page":"1","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"r020","doi-asserted-by":"publisher","DOI":"10.1086\/520433"},{"key":"r021","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.156.2.177"},{"key":"r022","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606063342302"},{"key":"r023","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199803000-00004"},{"key":"r024","doi-asserted-by":"publisher","DOI":"10.1038\/nm0597-533"},{"key":"r025","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/174.5.986"},{"key":"r026","doi-asserted-by":"publisher","DOI":"10.1001\/jama.275.3.194"},{"key":"r027","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/22.3.437"},{"key":"r028","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/175.3.590"},{"key":"r029","doi-asserted-by":"publisher","DOI":"10.1086\/516104"},{"key":"r030","unstructured":"Kedree MA. High prevalence of trimethoprim-sulfamethoxazole (TMP-SMX) resistant Streptococcus pneumoniae in HIV-infected patients on TMP-SMX for Pneumocystis prophylaxis: therapeutic implications. In: Program and abstracts of the 11th International Conference on AIDS, Vancouver, B.C., July 7\u201312, 1996. Vancouver, B.C.: XI Conference on AIDS Society, 1996:232. abstract."},{"key":"r031","unstructured":"Aberg JA, Yajko DM, Jacobson MA, Flamm R, Notario GF. The development of macrolide resistance to respiratory flora in patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis. In: Programs and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26\u201329, 1999. Washington, D.C.: American Society for Microbiology, 1999:1164. abstract."},{"key":"r032","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199806010-00003"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJM200004133421503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T21:47:02Z","timestamp":1513460822000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/abs\/10.1056\/NEJM200004133421503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4,13]]},"references-count":32,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2000,4,13]]}},"alternative-id":["10.1056\/NEJM200004133421503"],"URL":"https:\/\/doi.org\/10.1056\/nejm200004133421503","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4,13]]}}}